Egalet Ltd. is a specialty pharma company focusing on pain management. Based on the Egalet technology, the company is developing a pipeline of abuse-resistant opioids that are nearing pivotal testing. Egalet has pioneered one of the world’s first erosion-based delivery technologies to enable the controlled release of drugs through gradual erosion of a tablet and has optimized the abuse deterrent properties that can be applied to a broad range of opioids and non-opioids.
Funding Rounds (2) - $24.3MUpdate
Board Members and Advisors (1)Update
Chairman of the Board of Directors
Mar 2, 2006
Enso Ventures is a venture capital firm investing in early-stage high-technology and bio-tech...
Index Ventures is a multi-stage international venture capital firm with deep sector expertise...
European early stage venture capital firm
Early Stage Tech and Life Sciences
- 02/06/14 -nasdaq.com